European Journal of Radiology
Volume 44, Issue 1 , Pages 5-9 , October 2002

Mandibular metastasis presenting as the initial maifestation of malignant pheochromocytoma

Received 9 April 2001 ,Accepted 21 May 2001.

References 

  1. Noshiro T, Shimizu K, Watanabe T, et al.  Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am. J. Hypertens. 2000;13:35–43
  2. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted?. Urology. 1999;53:679–683
  3. Lynn MD, Braunstein EM, Wahl RL, Shapiro B, Gross MD, Rabbani R. Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging. Radiology. 1986;160:701–706
  4. Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: a positive correlation between MIB-1 staining and malignant tumor behavior. Cancer. 1999;86:1583–1589
  5. Nativ O, Grant CS, Sheps SG, et al.  The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer. 1992;69:2683–2687
  6. Boraschi P, Braccini G, Grassi L, et al.  Incidentally discovered adrenal masses: evaluation with gadolinium enhancement and fat-suppressed MR imaging at 0.5 T. Eur. J. Radiol. 1997;24:245–252
  7. Oishi S, Sasaki M, Sato T. Elevated immunoreactive endothelin levels in patients with pheochromocytoma. Am. J. Hypertens. 1994;7:717–722
  8. Fields RT, Byrd DL, Preskitt JT. Malignant pheochromocytoma with mandibular metastasis. J. Oral Maxillofac. Surg. 1998;56:979–984
  9. Vasen HF, van der Feltz M, Raue F, Kruseman AN, Koppeschaar HP, Pieters G, et al. The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch. Intern. Med. 1992;152:1250–1252
  10. Yamamoto Y, Isobe Y, Nishiyama Y, Takashima H, Ohkawa M, Kihara M, et al. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B. Clin. Nucl. Med. 1998;23:13–15
  11. Akama H, Noshiro T, Kimura N, Shimizu K, Watanabe T, Shibukawa S, et al. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma andpheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene. Intern. Med. 1999;38:145–149
  12. Chen MY, Chew EY, Reynolds JC, Chao DL, Oldfield EH. Metastatic brainstem pheochromocytoma in a patient with von Hippel-Lindau disease. Case illustration. J. Neurosurg. 2001;94:138
  13. Yanagi Y, Kishi K. Dynamic MRI in oral and maxillofacial region. Jpn J Med Imaging, Feb. 11–13, 1999, Tokyo.
  14. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J. Nucl. Med. 1985;26:576–585
  15. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology. 1993;186:711–715
  16. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology. 1999;212:35–41
  17. Von Moll L, McEwan AJ, Shapiro B, Sisson JC, Gross MD, Lloyd R, et al. Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma. J. Nucl. Med. 1987;28:979–988

PII: S0720-048X(01)00366-7

European Journal of Radiology
Volume 44, Issue 1 , Pages 5-9 , October 2002

Article Tools

* Image Usage & Resolution